Fig. 1.
The slow-release dexamethasone in proliferative vitreoretinopathy (PVR) prospective, randomized controlled clinical trial showed that a slow-release Dexamethasone injection given at the time of vitrectomy surgery and repeated at the time of oil removal does not increase the anatomic success rate at 6 months in eyes with rhegmatogenous retinal detachment with grade C PVR. There was also no change in visual acuity, however there was a statistical reduction in cystoid macular oedema. CI confidence interval.
Reference to original study: Banerjee, P. et al., 2017. Slow-Release Dexamethasone in Proliferative Vitreoretinopathy. Ophthalmology, 124(6), pp.757–767.
Compliance with ethical standards
Conflict of interest
The authors declare no competing interest.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.